BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$99.39
−0.11%Margins
Gross margin
71.3%
EBITDA margin
12.6%
EBIT margin
10.9%
Net margin
8.4%
FCF margin
8.3%
6.2%
Return on equity
4.6%
Return on assets
6.4%
Return on invested capital
0.56x
Asset turnover
$45.4M
Cash from operations
$12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026